Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Chemotherapy Versus Standard Treatment in Locally Advanced Colon Cancer
NCT01918527Phase 3Completed
- Sponsor
- Vejle Hospital
- Start
- Sep 2013
- Primary completion
- Jun 2023
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of capecitabine, oxaliplatin in colon cancer, sponsored by Vejle Hospital. Started Sep 2013; status: completed.
02
Drugs
capecitabineoxaliplatin
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT01918527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01918527.